CARMUSTINE

CARMUSTINE was reported 4718 times

CARMUSTINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADENOVIRAL ENCEPHALITIS 3 0.2727
1 SERTOLI-CELL-ONLY SYNDROME 4 0.2667
2 MALIGNANT TRANSFORMATION 88 0.1960
3 BLOOD STEM CELL TRANSPLANT FAILURE 36 0.1674
4 HERPETIC STOMATITIS 3 0.1579
5 EPILEPSIA PARTIALIS CONTINUA 6 0.1429
6 MENINGITIS EOSINOPHILIC 4 0.1333
7 URETERIC COMPRESSION 10 0.1316
8 HODGKIN'S DISEASE RECURRENT 3 0.1250
9 PERITONEAL LESION 10 0.1235
10 PERSISTENT GENERALISED LYMPHADENOPATHY 3 0.1200
11 PNEUMOCEPHALUS 38 0.1148
12 LYMPHADENITIS VIRAL 4 0.1000
13 PLEUROPARENCHYMAL FIBROELASTOSIS 10 0.0962
14 GASTROENTERITIS ADENOVIRUS 15 0.0955
15 SPHEROCYTIC ANAEMIA 6 0.0870
16 MENINGOENCEPHALITIS AMOEBIC 5 0.0862
17 HEPATIC ANGIOSARCOMA 6 0.0822
18 REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA 8 0.0784
19 PNEUMONIA ADENOVIRAL 15 0.0758
20 MANTLE CELL LYMPHOMA RECURRENT 29 0.0667
21 METASTASES TO RETROPERITONEUM 11 0.0647
22 ADENOVIRAL HEPATITIS 15 0.0638
23 METASTASES TO MUSCLE 11 0.0608
24 POLYCHROMASIA 18 0.0600
25 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 5 0.0562
26 AUTOLOGOUS BONE MARROW TRANSPLANTATION THERAPY 3 0.0536
27 IMPLANT SITE OEDEMA 5 0.0515
28 PSEUDOMENINGOCELE 8 0.0510
29 HUMAN HERPESVIRUS 7 INFECTION 4 0.0506
30 CSF CULTURE POSITIVE 5 0.0472
31 IMPLANT SITE NECROSIS 4 0.0455
32 INTRACRANIAL HYPOTENSION 29 0.0444
33 B-CELL LYMPHOMA RECURRENT 24 0.0442
34 ACANTHAMOEBA INFECTION 8 0.0426
35 OROPHARYNGEAL SQUAMOUS CELL CARCINOMA 6 0.0417
36 ANTICONVULSANT TOXICITY 2 0.0400
37 ENGRAFTMENT SYNDROME 23 0.0389
38 METASTATIC LYMPHOMA 15 0.0384
39 ALEXIA 3 0.0370
40 MENINGOCOCCAL SEPSIS 7 0.0368
41 CARDIOMYOPATHY ACUTE 8 0.0365
42 ANAL SQUAMOUS CELL CARCINOMA 11 0.0357
43 HERPES SIMPLEX TEST POSITIVE 7 0.0352
44 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 23 0.0351
45 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 77 0.0349
46 AZOOSPERMIA 13 0.0339
47 B-CELL LYMPHOMA REFRACTORY 3 0.0337
48 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 4 0.0328
49 SENSORY PROCESSING DISORDER 5 0.0296
50 METASTASES TO CHEST WALL 10 0.0288
51 RETICULOCYTOSIS 6 0.0283
52 PROPIONIBACTERIUM INFECTION 3 0.0280
53 ENGRAFT FAILURE 8 0.0279
54 ENTEROBACTER SEPSIS 10 0.0270
55 METASTASES TO SPLEEN 11 0.0266
56 ENCEPHALITIS ENTEROVIRAL 3 0.0265
57 HERPES SIMPLEX REACTIVATION 10 0.0262
58 FUSOBACTERIUM INFECTION 3 0.0256
59 HEPATIC INFECTION FUNGAL 3 0.0250
60 THROMBOPHLEBITIS SEPTIC 5 0.0244
61 FOLLICULAR LYMPHOMA 21 0.0239
62 IDIOPATHIC PNEUMONIA SYNDROME 7 0.0235
63 HUMAN HERPESVIRUS 8 INFECTION 14 0.0230
64 QUADRANTANOPIA 3 0.0229
65 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 19 0.0225
66 JC VIRUS INFECTION 36 0.0225
67 COLORECTAL ADENOCARCINOMA 5 0.0223
68 AMERICAN TRYPANOSOMIASIS 6 0.0222
69 METASTASES TO BONE MARROW 11 0.0220
70 AUTOIMMUNE PANCYTOPENIA 2 0.0220
71 CSF HIV ESCAPE SYNDROME 3 0.0217
72 CANDIDA PNEUMONIA 7 0.0217
73 STEM CELL TRANSPLANT 54 0.0216
74 CAPNOCYTOPHAGA INFECTION 2 0.0213
75 MALIGNANT GLIOMA 3 0.0211
76 MYELODYSPLASTIC SYNDROME 301 0.0208
77 HUMAN POLYOMAVIRUS INFECTION 11 0.0207
78 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES 6 0.0205
79 SUBDURAL HYGROMA 6 0.0197
80 MANTLE CELL LYMPHOMA 30 0.0197
81 RESPIRATORY TRACT INFECTION FUNGAL 10 0.0189
82 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 6 0.0183
83 CYSTITIS VIRAL 7 0.0183
84 MENINGITIS CHEMICAL 4 0.0182
85 HUMAN HERPESVIRUS 6 ENCEPHALITIS 5 0.0176
86 HEPATITIS CHRONIC ACTIVE 3 0.0174
87 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 3 0.0172
88 COLD TYPE HAEMOLYTIC ANAEMIA 4 0.0170
89 CEREBROSPINAL FLUID RETENTION 2 0.0169
90 KLEBSIELLA BACTERAEMIA 16 0.0168
91 JEJUNAL PERFORATION 4 0.0166
92 NEUTROPENIC COLITIS 34 0.0164
93 BLINDNESS CORTICAL 8 0.0163
94 SPLENIC LESION 6 0.0162
95 HEMIANOPIA 16 0.0161
96 HIP DEFORMITY 7 0.0160
97 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 5 0.0160
98 PULMONARY HILUM MASS 3 0.0160
99 ANOSOGNOSIA 12 0.0156
100 IMPLANT SITE REACTION 7 0.0154
101 VOLVULUS OF SMALL BOWEL 3 0.0152
102 REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA 3 0.0152
103 LENTIGO MALIGNA 4 0.0149
104 GRANULOCYTES ABNORMAL 3 0.0149
105 MICROPHTHALMOS 4 0.0147
106 VENOOCCLUSIVE DISEASE 36 0.0144
107 POST PROCEDURAL HYPOTHYROIDISM 3 0.0142
108 AUTOIMMUNE THROMBOCYTOPENIA 6 0.0139
109 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 5 0.0137
110 EXTRADURAL HAEMATOMA 18 0.0136
111 VENOOCCLUSIVE LIVER DISEASE 67 0.0136
112 HEPATITIS E 21 0.0133
113 BRUCELLOSIS 2 0.0132
114 SECOND PRIMARY MALIGNANCY 110 0.0132
115 CEREBRAL CYST 9 0.0131
116 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 17 0.0129
117 URAEMIC ENCEPHALOPATHY 4 0.0128
118 SCEDOSPORIUM INFECTION 9 0.0127
119 ACUTE PULMONARY HISTOPLASMOSIS 2 0.0126
120 INCISION SITE INFECTION 11 0.0121
121 ACUTE MYELOMONOCYTIC LEUKAEMIA 3 0.0119
122 CEREBROSPINAL FLUID LEAKAGE 22 0.0119
123 BRAIN ABSCESS 30 0.0118
124 ERYTHEMA INFECTIOSUM 3 0.0117
125 HUMAN HERPESVIRUS 6 INFECTION 22 0.0116
126 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 11 0.0116
127 PROCEDURAL SITE REACTION 6 0.0115
128 ENCEPHALITIS CYTOMEGALOVIRUS 5 0.0114
129 TERMINAL ILEITIS 7 0.0114
130 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 4 0.0114
131 ADENOVIRUS INFECTION 33 0.0114
132 VASOGENIC CEREBRAL OEDEMA 8 0.0111
133 CYTOMEGALOVIRUS INFECTION REACTIVATION 49 0.0111
134 ACUTE MYELOID LEUKAEMIA 172 0.0110
135 CEREBRAL MASS EFFECT 4 0.0110
136 CULTURE STOOL POSITIVE 3 0.0109
137 BRAIN OEDEMA 138 0.0109
138 PNEUMOCYSTIS JIROVECI INFECTION 3 0.0108
139 INCISION SITE COMPLICATION 9 0.0108
140 LUNG INFECTION PSEUDOMONAL 6 0.0108
141 POSTOPERATIVE FEVER 3 0.0107
142 URETERITIS 3 0.0107
143 DISSEMINATED CRYPTOCOCCOSIS 8 0.0106
144 PNEUMONIA MYCOPLASMAL 8 0.0101
145 DIAPHRAGMATIC PARALYSIS 6 0.0100
146 CLOSTRIDIUM COLITIS 12 0.0099
147 FEBRILE BONE MARROW APLASIA 42 0.0099
148 MYOCARDIAL RUPTURE 3 0.0098
149 UREAPLASMA INFECTION 4 0.0098
150 MUCOSAL INFLAMMATION 256 0.0098
151 GASTROINTESTINAL FUNGAL INFECTION 5 0.0097
152 WOUND DEBRIDEMENT 4 0.0096
153 GLIOBLASTOMA MULTIFORME 8 0.0095
154 BACTERIAL TRANSLOCATION 3 0.0095
155 VIRAEMIA 13 0.0094
156 MONOCLONAL IMMUNOGLOBULIN PRESENT 7 0.0092
157 CNS VENTRICULITIS 3 0.0092
158 GASTROENTERITIS ESCHERICHIA COLI 5 0.0091
159 ASPERGILLUS INFECTION 60 0.0091
160 BRAIN MASS 3 0.0089
161 GAS GANGRENE 3 0.0087
162 INFECTION REACTIVATION 10 0.0087
163 DIFFUSE LARGE B-CELL LYMPHOMA 66 0.0086
164 DISSEMINATED ASPERGILLOSIS 4 0.0085
165 ANAEMIA HAEMOLYTIC AUTOIMMUNE 7 0.0085
166 DYSPLASTIC NAEVUS 3 0.0083
167 APLASIA 16 0.0082
168 ESCHERICHIA BACTERAEMIA 19 0.0081
169 SENSORIMOTOR DISORDER 4 0.0080
170 VIRAL MYOCARDITIS 3 0.0080
171 PERIPHERAL SENSORIMOTOR NEUROPATHY 10 0.0080
172 PARAINFLUENZAE VIRUS INFECTION 12 0.0079
173 LIPID METABOLISM DISORDER 3 0.0078
174 BLOOD BILIRUBIN ABNORMAL 10 0.0078
175 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 64 0.0078
176 PELVIC VENOUS THROMBOSIS 11 0.0077
177 EXTRADURAL ABSCESS 6 0.0076
178 ACUTE GRAFT VERSUS HOST DISEASE 35 0.0076
179 BRAIN MIDLINE SHIFT 4 0.0076
180 TRICHOSPORON INFECTION 3 0.0074
181 PHARYNGEAL INFLAMMATION 9 0.0074
182 CSF PROTEIN INCREASED 6 0.0072
183 EPSTEIN-BARR VIRAEMIA 8 0.0072
184 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 9 0.0072
185 CHRONIC GRAFT VERSUS HOST DISEASE 26 0.0072
186 BRAIN SCAN ABNORMAL 4 0.0072
187 NEUTROPENIC SEPSIS 51 0.0071
188 PNEUMONIA PRIMARY ATYPICAL 4 0.0071
189 HAEMATOTOXICITY 67 0.0070
190 BILIARY OBSTRUCTION 9 0.0069
191 ENTEROCOCCAL INFECTION 33 0.0068
192 QUADRIPARESIS 11 0.0066
193 ENCEPHALITIS VIRAL 8 0.0066
194 ASPERGILLUS TEST POSITIVE 2 0.0065
195 CYTOMEGALOVIRUS ENTEROCOLITIS 5 0.0065
196 APOPTOSIS 2 0.0065
197 ZYGOMYCOSIS 3 0.0064
198 POSTOPERATIVE INFECTION 3 0.0063
199 CONJUNCTIVAL HAEMORRHAGE 24 0.0063
200 GLIOMA 4 0.0062
201 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 11 0.0062
202 KLEBSIELLA SEPSIS 7 0.0062
203 ESCHERICHIA SEPSIS 18 0.0062
204 CENTRAL NERVOUS SYSTEM INFECTION 7 0.0061
205 NEUROLOGICAL DECOMPENSATION 14 0.0060
206 MYELOPROLIFERATIVE NEOPLASM 4 0.0060
207 FEBRILE NEUTROPENIA 400 0.0060
208 CULTURE POSITIVE 5 0.0060
209 INFERTILITY 9 0.0060
210 CSF TEST ABNORMAL 3 0.0060
211 HYPOGAMMAGLOBULINAEMIA 39 0.0059
212 PNEUMONIA INFLUENZAL 7 0.0059
213 OSTEOLYSIS 12 0.0059
214 ENTEROVIRUS INFECTION 5 0.0058
215 RELAPSING-REMITTING MULTIPLE SCLEROSIS 5 0.0058
216 SUBILEUS 12 0.0058
217 STEROID DEPENDENCE 5 0.0057
218 MYOSITIS 51 0.0057
219 BRONCHOPULMONARY ASPERGILLOSIS 44 0.0057
220 ENTEROCOCCAL BACTERAEMIA 6 0.0057
221 HEPATIC CYST 19 0.0056
222 CANDIDA SEPSIS 5 0.0056
223 STREPTOCOCCAL BACTERAEMIA 6 0.0055
224 HAEMORRHAGIC INFARCTION 3 0.0055
225 PNEUMOCYSTIS JIROVECII PNEUMONIA 54 0.0054
226 CEREBRAL TOXOPLASMOSIS 5 0.0054
227 HYPERMETROPIA 5 0.0053
228 PULMONARY TOXICITY 37 0.0052
229 CYSTITIS HAEMORRHAGIC 21 0.0052
230 ENTEROCOLITIS 30 0.0052
231 GRAFT VERSUS HOST DISEASE 37 0.0051
232 SYSTEMIC MYCOSIS 6 0.0051
233 PNEUMOCOCCAL INFECTION 3 0.0051
234 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 14 0.0051
235 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 3 0.0051
236 JUGULAR VEIN THROMBOSIS 9 0.0051
237 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 7 0.0050
238 MENINGITIS BACTERIAL 7 0.0049
239 ENTERITIS 31 0.0048
240 LEUKOENCEPHALOPATHY 18 0.0048
241 POSTICTAL STATE 5 0.0048
242 HYDROCEPHALUS 26 0.0048
243 CYTOMEGALOVIRUS VIRAEMIA 21 0.0047
244 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 10 0.0047
245 HYPOREFLEXIA 9 0.0047
246 PSEUDOMONAL BACTERAEMIA 4 0.0047
247 PNEUMONIA CYTOMEGALOVIRAL 9 0.0046
248 ABDOMINAL LYMPHADENOPATHY 4 0.0046
249 THERAPY PARTIAL RESPONDER 71 0.0045
250 CHRONIC MYELOMONOCYTIC LEUKAEMIA 3 0.0045
251 CYTOMEGALOVIRUS INFECTION 74 0.0044
252 CAECITIS 2 0.0044
253 HEMIPLEGIA 37 0.0044
254 OSTEOSCLEROSIS 7 0.0044
255 SURGICAL PROCEDURE REPEATED 3 0.0044
256 ACUTE RESPIRATORY DISTRESS SYNDROME 77 0.0043
257 PNEUMONIA KLEBSIELLA 8 0.0043
258 EXTENSOR PLANTAR RESPONSE 4 0.0043
259 ARACHNOIDITIS 3 0.0043
260 OTOTOXICITY 8 0.0043
261 PULMONARY VENO-OCCLUSIVE DISEASE 3 0.0043
262 MEAN CELL VOLUME INCREASED 11 0.0043
263 GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0042
264 CARDIOTOXICITY 37 0.0041
265 CYTOPENIA 50 0.0041
266 CEREBRAL VASOCONSTRICTION 3 0.0041
267 PNEUMOCYSTIS JIROVECI PNEUMONIA 9 0.0040
268 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 3 0.0040
269 URINARY TRACT INFECTION BACTERIAL 10 0.0040
270 CATHETER RELATED INFECTION 4 0.0039
271 BK VIRUS INFECTION 13 0.0039
272 EPSTEIN-BARR VIRUS INFECTION 24 0.0038
273 FUNGAEMIA 6 0.0038
274 OPHTHALMOPLEGIA 6 0.0038
275 PNEUMONIA FUNGAL 15 0.0038
276 WOUND DRAINAGE 3 0.0038
277 INTRA-ABDOMINAL HAEMORRHAGE 9 0.0038
278 RADIATION INJURY 4 0.0038
279 LYMPHADENITIS 9 0.0037
280 BLOOD IMMUNOGLOBULIN A INCREASED 2 0.0037
281 IIIRD NERVE PARALYSIS 3 0.0037
282 ENTEROCOCCAL SEPSIS 3 0.0037
283 BRAIN HERNIATION 11 0.0037
284 ATYPICAL PNEUMONIA 11 0.0037
285 BLOOD CULTURE POSITIVE 11 0.0037
286 RENAL ABSCESS 3 0.0037
287 THROMBOCYTOPENIC PURPURA 5 0.0037
288 PAPILLOMA VIRAL INFECTION 6 0.0036
289 CENTRAL NERVOUS SYSTEM LYMPHOMA 5 0.0036
290 COLLAPSE OF LUNG 3 0.0036
291 BLOOD PH INCREASED 2 0.0036
292 SEPTIC EMBOLUS 3 0.0036
293 OESOPHAGEAL PERFORATION 3 0.0036
294 CYTOMEGALOVIRUS CHORIORETINITIS 7 0.0036
295 CARDIAC TAMPONADE 17 0.0036
296 BONE FRAGMENTATION 2 0.0036
297 NEOPLASM RECURRENCE 12 0.0035
298 GASTROINTESTINAL TOXICITY 17 0.0035
299 NEUROPATHY 6 0.0035
300 COMPUTERISED TOMOGRAM ABNORMAL 8 0.0035
301 CYTOMEGALOVIRUS COLITIS 8 0.0035
302 WOUND INFECTION STAPHYLOCOCCAL 6 0.0035
303 HYPOPITUITARISM 6 0.0034
304 ORGANISING PNEUMONIA 17 0.0034
305 LUNG INFILTRATION 30 0.0034
306 BONE MARROW TOXICITY 4 0.0034
307 BACTERIAL SEPSIS 11 0.0034
308 VARICELLA ZOSTER VIRUS INFECTION 7 0.0034
309 AREFLEXIA 9 0.0034
310 BACTERAEMIA 40 0.0034
311 KLEBSIELLA INFECTION 17 0.0034
312 COCCIDIOIDOMYCOSIS 4 0.0034
313 PARVOVIRUS B19 INFECTION 3 0.0034
314 BASAL CELL CARCINOMA 51 0.0033
315 VASOSPASM 3 0.0033
316 ABULIA 3 0.0032
317 URINARY TRACT INFECTION ENTEROCOCCAL 3 0.0032
318 ACUTE LYMPHOCYTIC LEUKAEMIA 9 0.0032
319 PLATELET DISORDER 8 0.0032
320 HEPATITIS B REACTIVATION 10 0.0031
321 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5 0.0031
322 HEPATOSPLENOMEGALY 8 0.0031
323 LYMPHOMA 48 0.0031
324 PURULENCE 6 0.0031
325 ASPERGILLOSIS 4 0.0031
326 DRUG CLEARANCE DECREASED 4 0.0031
327 CYTOKINE RELEASE SYNDROME 61 0.0030
328 DEAFNESS BILATERAL 5 0.0029
329 RECURRENT CANCER 12 0.0029
330 GLIOBLASTOMA 5 0.0029
331 CAROTID ARTERIOSCLEROSIS 3 0.0029
332 PUPIL FIXED 5 0.0029
333 INTRACRANIAL PRESSURE INCREASED 16 0.0029
334 TUMOUR NECROSIS 3 0.0028
335 LYMPHOPENIA 40 0.0028
336 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 14 0.0028
337 TACHYARRHYTHMIA 7 0.0028
338 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
339 ANTIBODY TEST ABNORMAL 2 0.0028
340 FINE MOTOR SKILL DYSFUNCTION 8 0.0028
341 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 4 0.0028
342 GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0027
343 MENINGITIS 18 0.0027
344 CARDIAC HYPERTROPHY 3 0.0027
345 PSEUDOMONAS INFECTION 23 0.0027
346 WOUND DEHISCENCE 9 0.0027
347 CLOSTRIDIAL INFECTION 9 0.0027
348 CYTOGENETIC ABNORMALITY 3 0.0027
349 SKIN TOXICITY 15 0.0027
350 CLOSTRIDIUM DIFFICILE COLITIS 28 0.0026
351 PUPILS UNEQUAL 3 0.0026
352 TUMOUR LYSIS SYNDROME 23 0.0026
353 CEREBRAL VENTRICLE DILATATION 3 0.0026
354 OSTEOCHONDROSIS 3 0.0026
355 ASEPTIC NECROSIS BONE 2 0.0026
356 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 13 0.0026
357 BLOOD FIBRINOGEN INCREASED 2 0.0025
358 APPENDICECTOMY 9 0.0025
359 PNEUMOCYSTIS JIROVECII INFECTION 3 0.0025
360 NEPHROPATHY TOXIC 28 0.0025
361 DISEASE PROGRESSION 292 0.0025
362 SEPTIC SHOCK 105 0.0024
363 GASTROINTESTINAL NECROSIS 7 0.0024
364 CEREBRAL HAEMATOMA 8 0.0024
365 STAPHYLOCOCCUS TEST POSITIVE 5 0.0024
366 MALIGNANT PLEURAL EFFUSION 4 0.0024
367 ESCHERICHIA URINARY TRACT INFECTION 10 0.0024
368 NECROSIS 13 0.0023
369 PHYSICAL DECONDITIONING 6 0.0023
370 BONE MARROW DISORDER 7 0.0023
371 THROMBOCYTOPENIA 252 0.0023
372 CANDIDIASIS 9 0.0022
373 TONGUE DRY 3 0.0022
374 GRANULOCYTE COUNT DECREASED 4 0.0022
375 HAEMOLYTIC URAEMIC SYNDROME 5 0.0022
376 ADENOCARCINOMA GASTRIC 2 0.0022
377 HERPES SIMPLEX 14 0.0022
378 CARDIAC DYSFUNCTION 8 0.0021
379 PLASMACYTOMA 4 0.0021
380 CULTURE URINE POSITIVE 3 0.0021
381 MYELITIS TRANSVERSE 3 0.0021
382 ANTICONVULSANT DRUG LEVEL DECREASED 3 0.0021
383 BONE MARROW TRANSPLANT 4 0.0021
384 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 3 0.0021
385 CANDIDA INFECTION 35 0.0021
386 BONE MARROW FAILURE 42 0.0021
387 PULMONARY SEPSIS 3 0.0021
388 PULMONARY VALVE INCOMPETENCE 3 0.0021
389 STATUS EPILEPTICUS 23 0.0020
390 POST PROCEDURAL COMPLICATION 39 0.0020
391 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 12 0.0020
392 STAPHYLOCOCCAL SEPSIS 10 0.0020
393 BLOOD LACTATE DEHYDROGENASE INCREASED 32 0.0020
394 STAPHYLOCOCCAL INFECTION 66 0.0020
395 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 19 0.0020
396 DEVICE RELATED SEPSIS 4 0.0020
397 EMBOLISM VENOUS 6 0.0020
398 GENITAL HERPES 3 0.0020
399 INTESTINAL PERFORATION 22 0.0020
400 ARTHRITIS BACTERIAL 8 0.0019
401 BONE LESION 7 0.0019
402 CAPILLARY LEAK SYNDROME 4 0.0019
403 GASTROINTESTINAL INFLAMMATION 15 0.0019
404 GASTROINTESTINAL STOMA COMPLICATION 3 0.0019
405 COLITIS 72 0.0019
406 PANCYTOPENIA 106 0.0019
407 ENCEPHALITIS 13 0.0019
408 NON-SMALL CELL LUNG CANCER 9 0.0019
409 ATAXIA 22 0.0019
410 MULTI-ORGAN FAILURE 32 0.0018
411 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
412 DRUG TOXICITY 25 0.0018
413 WOUND INFECTION 20 0.0018
414 DEVICE RELATED INFECTION 28 0.0018
415 CARDIAC AMYLOIDOSIS 2 0.0018
416 HEPATOTOXICITY 40 0.0018
417 GLOMERULAR FILTRATION RATE DECREASED 22 0.0018
418 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
419 POSTOPERATIVE WOUND INFECTION 12 0.0018
420 PNEUMONITIS 48 0.0018
421 METASTASES TO MENINGES 4 0.0018
422 TONGUE COATED 3 0.0017
423 PARTIAL SEIZURES 9 0.0017
424 BRONCHIOLITIS 6 0.0017
425 ESCHERICHIA INFECTION 14 0.0017
426 LEUKOPENIA 85 0.0017
427 MULTIPLE ORGAN DYSFUNCTION SYNDROME 48 0.0017
428 LYMPHADENOPATHY 59 0.0017
429 SOFT TISSUE INFECTION 3 0.0016
430 TRANSPLANT FAILURE 4 0.0016
431 HEPATOCELLULAR INJURY 23 0.0016
432 HEPATIC LESION 7 0.0016
433 MYELOSUPPRESSION 58 0.0016
434 NEUROTOXICITY 28 0.0016
435 OSTEITIS 4 0.0016
436 HYPOPROTEINAEMIA 3 0.0016
437 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
438 NEUTROPENIA 211 0.0016
439 SKIN NECROSIS 8 0.0015
440 METASTASIS 11 0.0015
441 PLASMA CELL MYELOMA RECURRENT 5 0.0015
442 WOUND SECRETION 6 0.0015
443 CHOLESTASIS 29 0.0015
444 MYOPATHY 13 0.0015
445 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
446 HEPATITIS B 9 0.0015
447 SMALL INTESTINAL HAEMORRHAGE 3 0.0015
448 HEMIPARESIS 25 0.0015
449 IMMUNOSUPPRESSION 13 0.0015
450 SUBARACHNOID HAEMORRHAGE 15 0.0015
451 B-CELL LYMPHOMA 5 0.0015
452 VENOUS THROMBOSIS LIMB 3 0.0015
453 SEPSIS 162 0.0015
454 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 3 0.0014
455 BACTERIAL INFECTION 27 0.0014
456 THROMBOTIC MICROANGIOPATHY 14 0.0014
457 DILATATION VENTRICULAR 3 0.0014
458 RENAL NEOPLASM 3 0.0014
459 NEOPLASM PROGRESSION 49 0.0014
460 LUNG NEOPLASM 6 0.0014
461 RETINAL HAEMORRHAGE 10 0.0014
462 TUMOUR HAEMORRHAGE 4 0.0014
463 LYMPHOCYTOSIS 3 0.0014
464 CEREBRAL INFARCTION 34 0.0014
465 ILEUS 17 0.0014
466 DISEASE RECURRENCE 65 0.0014
467 SPINAL COLUMN INJURY 3 0.0013
468 AGRANULOCYTOSIS 25 0.0013
469 PSEUDOMEMBRANOUS COLITIS 3 0.0013
470 NORMOCHROMIC NORMOCYTIC ANAEMIA 4 0.0013
471 HEPATOCELLULAR DAMAGE 3 0.0013
472 NYSTAGMUS 7 0.0013
473 HAEMODIALYSIS 11 0.0013
474 PNEUMONIA BACTERIAL 12 0.0013
475 MULTIPLE-DRUG RESISTANCE 4 0.0013
476 APPENDICITIS 12 0.0013
477 PULMONARY HAEMORRHAGE 10 0.0013
478 INFECTION 183 0.0013
479 MALIGNANT NEOPLASM PROGRESSION 129 0.0013
480 ACUTE LEUKAEMIA 2 0.0012
481 STOMATITIS 75 0.0012
482 SLOW SPEECH 3 0.0012
483 HEPATITIS ACUTE 8 0.0012
484 GRANULOCYTOPENIA 7 0.0012
485 NEUROLOGICAL SYMPTOM 7 0.0012
486 HERPES VIRUS INFECTION 7 0.0012
487 CYTOLYTIC HEPATITIS 4 0.0012
488 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
489 SYSTEMIC CANDIDA 3 0.0012
490 RESPIRATORY FAILURE 87 0.0012
491 SYMPTOM RECURRENCE 7 0.0012
492 BLOOD AMYLASE INCREASED 2 0.0012
493 WOUND COMPLICATION 4 0.0012
494 VENTRICULAR DYSFUNCTION 3 0.0012
495 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
496 APLASTIC ANAEMIA 6 0.0011
497 ATELECTASIS 11 0.0011
498 METASTASES TO LUNG 13 0.0011
499 CONVULSION 63 0.0011
500 HAEMOGLOBIN ABNORMAL 7 0.0011
501 POLYNEUROPATHY 13 0.0011
502 SERUM SICKNESS 3 0.0011
503 LUNG CONSOLIDATION 3 0.0011
504 ANGIOPATHY 6 0.0011
505 NEUTROPHIL COUNT ABNORMAL 3 0.0011
506 CLOSTRIDIUM DIFFICILE INFECTION 23 0.0011
507 SUBDURAL HAEMATOMA 15 0.0010
508 HYPOVOLAEMIC SHOCK 5 0.0010
509 ADRENAL DISORDER 2 0.0010
510 GUILLAIN-BARRE SYNDROME 5 0.0010
511 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
512 HYPOALBUMINAEMIA 8 0.0010
513 APHASIA 31 0.0010
514 LYMPHOPROLIFERATIVE DISORDER 3 0.0010
515 VENOUS THROMBOSIS 4 0.0010
516 TUBULOINTERSTITIAL NEPHRITIS 19 0.0010
517 PNEUMOTHORAX 16 0.0010
518 HAEMORRHAGE INTRACRANIAL 15 0.0010
519 BLOOD BILIRUBIN INCREASED 27 0.0010
520 RESPIRATORY TRACT INFECTION 26 0.0010
521 TOXIC SKIN ERUPTION 10 0.0010
522 ORGAN FAILURE 4 0.0010
523 ACUTE RESPIRATORY FAILURE 19 0.0010
524 PATHOGEN RESISTANCE 9 0.0010
525 END STAGE RENAL DISEASE 18 0.0010
526 PROSTATITIS 3 0.0010
527 DYSAESTHESIA 3 0.0010
528 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
529 HYPERBILIRUBINAEMIA 10 0.0010
530 AORTIC VALVE INCOMPETENCE 4 0.0009
531 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
532 FUNGAL INFECTION 31 0.0009
533 ABSCESS INTESTINAL 2 0.0009
534 PSYCHOLOGICAL TRAUMA 8 0.0009
535 MONOPLEGIA 4 0.0009
536 LYMPHOCYTE COUNT INCREASED 3 0.0009
537 HAEMODYNAMIC INSTABILITY 7 0.0009
538 THROMBOSIS IN DEVICE 3 0.0009
539 CEREBELLAR SYNDROME 2 0.0009
540 SPINAL OSTEOARTHRITIS 8 0.0009
541 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
542 PARALYSIS 13 0.0009
543 GASTRIC CANCER 23 0.0009
544 DRUG ERUPTION 16 0.0009
545 ILEUS PARALYTIC 4 0.0009
546 ALANINE AMINOTRANSFERASE INCREASED 55 0.0009
547 METASTASES TO SPINE 3 0.0009
548 ACUTE PULMONARY OEDEMA 5 0.0009
549 PAPILLOEDEMA 4 0.0009
550 SUSPECTED OFF LABEL USE 4 0.0009
551 NEUTROPHIL COUNT DECREASED 36 0.0009
552 OSTEONECROSIS 29 0.0009
553 CARDIOMYOPATHY 13 0.0009
554 LARGE INTESTINE PERFORATION 6 0.0009
555 POST PROCEDURAL INFECTION 7 0.0009
556 STRESS CARDIOMYOPATHY 5 0.0009
557 MULTIPLE MYELOMA 4 0.0009
558 ENCEPHALOPATHY 21 0.0009
559 PULMONARY EMBOLISM 81 0.0009
560 THROMBOTIC THROMBOCYTOPENIC PURPURA 3 0.0009
561 COVID-19 PNEUMONIA 10 0.0008
562 EMBOLISM 7 0.0008
563 SARCOIDOSIS 4 0.0008
564 VIRAL INFECTION 28 0.0008
565 NERVOUS SYSTEM DISORDER 26 0.0008
566 FAECAL INCONTINENCE 4 0.0008
567 PERICARDIAL EFFUSION 19 0.0008
568 AUTOIMMUNE DISORDER 8 0.0008
569 HEPATITIS 21 0.0008
570 NEUROPATHY PERIPHERAL 78 0.0008
571 HYPOPHOSPHATAEMIA 6 0.0008
572 RENAL FAILURE ACUTE 34 0.0008
573 DERMATITIS EXFOLIATIVE 4 0.0008
574 PROTEIN TOTAL DECREASED 3 0.0008
575 LYMPHOCYTE COUNT DECREASED 14 0.0008
576 DEEP VEIN THROMBOSIS 51 0.0008
577 PROCEDURAL COMPLICATION 6 0.0008
578 COAGULOPATHY 13 0.0008
579 ENDOCARDITIS 4 0.0008
580 CACHEXIA 4 0.0008
581 EJECTION FRACTION DECREASED 12 0.0008
582 PROSTATOMEGALY 3 0.0008
583 SCAR 13 0.0008
584 IMMUNE SYSTEM DISORDER 10 0.0008
585 MENTAL STATUS CHANGES 21 0.0008
586 INTENTIONAL PRODUCT USE ISSUE 66 0.0008
587 CEREBRAL ATROPHY 3 0.0008
588 DRUG RESISTANCE 19 0.0007
589 GOITRE 3 0.0007
590 HYPERURICAEMIA 3 0.0007
591 DEAFNESS 19 0.0007
592 EUGLYCAEMIC DIABETIC KETOACIDOSIS 3 0.0007
593 PYREXIA 242 0.0007
594 DRUG LEVEL DECREASED 7 0.0007
595 HYPOVOLAEMIA 4 0.0007
596 METASTASES TO LIVER 12 0.0007
597 ABDOMINAL ABSCESS 3 0.0007
598 PULMONARY FIBROSIS 13 0.0007
599 MENINGITIS ASEPTIC 3 0.0007
600 SUDDEN DEATH 7 0.0007
601 HYPERTHERMIA 5 0.0007
602 CHEST X-RAY ABNORMAL 2 0.0007
603 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
604 BRAIN DEATH 2 0.0006
605 OLIGURIA 4 0.0006
606 OESOPHAGITIS 7 0.0006
607 PNEUMONIA 206 0.0006
608 DERMATITIS ALLERGIC 8 0.0006
609 PRODUCT USE IN UNAPPROVED INDICATION 157 0.0006
610 RENAL TUBULAR NECROSIS 6 0.0006
611 PLATELET COUNT DECREASED 65 0.0006
612 NASAL POLYPS 3 0.0006
613 ANAEMIA 116 0.0006
614 WALKING AID USER 4 0.0006
615 DIABETIC NEUROPATHY 3 0.0006
616 ABDOMINAL TENDERNESS 3 0.0006
617 HYPERNATRAEMIA 3 0.0006
618 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
619 HYPOXIA 21 0.0006
620 ATRIAL FIBRILLATION 58 0.0006
621 OFF LABEL USE 521 0.0006
622 EMPHYSEMA 6 0.0006
623 LUNG DISORDER 29 0.0006
624 HERPES ZOSTER 34 0.0006
625 EYELID PTOSIS 6 0.0006
626 CEREBRAL HAEMORRHAGE 21 0.0006
627 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 6 0.0006
628 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
629 PLEURAL EFFUSION 35 0.0006
630 PETECHIAE 6 0.0006
631 CAROTID ARTERY STENOSIS 2 0.0006
632 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
633 ASPARTATE AMINOTRANSFERASE INCREASED 30 0.0006
634 JAUNDICE 15 0.0006
635 RASH PUSTULAR 4 0.0005
636 IMPAIRED HEALING 18 0.0005
637 JAW DISORDER 3 0.0005
638 INTESTINAL ISCHAEMIA 3 0.0005
639 ACUTE KIDNEY INJURY 83 0.0005
640 RASH MACULO-PAPULAR 12 0.0005
641 SQUAMOUS CELL CARCINOMA 5 0.0005
642 HEPATIC FAILURE 16 0.0005
643 PERONEAL NERVE PALSY 3 0.0005
644 COMA 25 0.0005
645 RENAL IMPAIRMENT 44 0.0005
646 PNEUMONIA ASPIRATION 13 0.0005
647 PULMONARY OEDEMA 23 0.0005
648 ILL-DEFINED DISORDER 31 0.0005
649 ASCITES 15 0.0005
650 HEPATOMEGALY 5 0.0005
651 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
652 PROTHROMBIN TIME PROLONGED 3 0.0005
653 RESPIRATORY DISORDER 15 0.0005
654 THYROID CANCER 6 0.0005
655 INTERSTITIAL LUNG DISEASE 24 0.0005
656 SINUS TACHYCARDIA 7 0.0005
657 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
658 EPILEPSY 15 0.0005
659 THERAPY NON-RESPONDER 22 0.0005
660 FLUID OVERLOAD 7 0.0005
661 GASTROENTERITIS 7 0.0005
662 DYSPNOEA EXERTIONAL 18 0.0005
663 CARDIAC FAILURE 38 0.0005
664 HEPATIC CYTOLYSIS 6 0.0005
665 HYPOTHYROIDISM 15 0.0005
666 IMMUNODEFICIENCY 7 0.0005
667 PYELONEPHRITIS 4 0.0005
668 ASPIRATION 5 0.0005
669 CORONAVIRUS INFECTION 3 0.0005
670 LUNG INFECTION 7 0.0005
671 VENTRICULAR FIBRILLATION 5 0.0004
672 URINARY RETENTION 15 0.0004
673 BRAIN NEOPLASM MALIGNANT 2 0.0004
674 GASTROINTESTINAL INFECTION 4 0.0004
675 MITRAL VALVE INCOMPETENCE 5 0.0004
676 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
677 NEPHROTIC SYNDROME 3 0.0004
678 SKIN LESION 12 0.0004
679 BRAIN NEOPLASM 4 0.0004
680 NEOPLASM 5 0.0004
681 GASTRIC HAEMORRHAGE 5 0.0004
682 UROSEPSIS 4 0.0004
683 TOXICITY TO VARIOUS AGENTS 73 0.0004
684 RENAL FAILURE 57 0.0004
685 SPLENOMEGALY 5 0.0004
686 VENTRICULAR TACHYCARDIA 7 0.0004
687 TONGUE DISORDER 3 0.0004
688 HEPATITIS C 5 0.0004
689 NO THERAPEUTIC RESPONSE 5 0.0004
690 LIVER INJURY 10 0.0004
691 CARDIOMEGALY 5 0.0004
692 BREATH SOUNDS ABNORMAL 2 0.0004
693 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
694 CYST 5 0.0004
695 PULMONARY MASS 6 0.0004
696 TOOTH EXTRACTION 5 0.0004
697 INTESTINAL OBSTRUCTION 15 0.0004
698 BODY TEMPERATURE INCREASED 8 0.0004
699 HYPOKALAEMIA 18 0.0004
700 MYDRIASIS 5 0.0004
701 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
702 OSTEOMYELITIS 7 0.0004
703 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
704 C-REACTIVE PROTEIN INCREASED 14 0.0004
705 FOLLICULITIS 4 0.0004
706 PULMONARY CONGESTION 5 0.0004
707 INCONTINENCE 4 0.0004
708 LIVER FUNCTION TEST ABNORMAL 11 0.0004
709 BLOOD DISORDER 3 0.0004
710 RHINITIS 3 0.0004
711 ANAL ABSCESS 2 0.0004
712 OEDEMA 20 0.0004
713 PROTEINURIA 7 0.0004
714 RESPIRATORY DISTRESS 10 0.0004
715 ACUTE CORONARY SYNDROME 3 0.0004
716 CARDIOGENIC SHOCK 5 0.0003
717 HAEMATOMA 9 0.0003
718 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
719 ACUTE MYOCARDIAL INFARCTION 10 0.0003
720 PURPURA 3 0.0003
721 ISCHAEMIC STROKE 6 0.0003
722 PLASMA CELL MYELOMA 13 0.0003
723 MOUTH ULCERATION 7 0.0003
724 WHITE BLOOD CELL COUNT DECREASED 36 0.0003
725 SMALL INTESTINAL OBSTRUCTION 4 0.0003
726 GENERALISED OEDEMA 4 0.0003
727 FEMUR FRACTURE 10 0.0003
728 PHARYNGITIS 4 0.0003
729 HEPATIC FUNCTION ABNORMAL 12 0.0003
730 HEPATIC ENCEPHALOPATHY 3 0.0003
731 COGNITIVE DISORDER 15 0.0003
732 DIARRHOEA HAEMORRHAGIC 3 0.0003
733 LEUKAEMIA 3 0.0003
734 CELLULITIS 16 0.0003
735 DELIRIUM 11 0.0003
736 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
737 GASTRIC ULCER 6 0.0003
738 TACHYCARDIA 28 0.0003
739 CARDIAC ARREST 26 0.0003
740 TRANSAMINASES INCREASED 7 0.0003
741 TREATMENT FAILURE 26 0.0003
742 ANOREXIA 4 0.0003
743 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
744 MUSCULAR WEAKNESS 35 0.0003
745 TINNITUS 14 0.0003
746 ORAL CANDIDIASIS 4 0.0003
747 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
748 HAEMOGLOBIN DECREASED 31 0.0003
749 BLOOD UREA INCREASED 5 0.0003
750 MALIGNANT MELANOMA 4 0.0003
751 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
752 BRONCHIECTASIS 2 0.0003
753 MULTIPLE SCLEROSIS 14 0.0003
754 MOBILITY DECREASED 21 0.0003
755 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
756 DRUG INTERACTION 46 0.0003
757 PERITONITIS 6 0.0003
758 COORDINATION ABNORMAL 4 0.0003
759 AMENORRHOEA 5 0.0003
760 HYPOTENSION 56 0.0003
761 VISUAL ACUITY REDUCED 9 0.0003
762 HYPERTENSIVE CRISIS 3 0.0003
763 MALNUTRITION 3 0.0003
764 HAEMORRHAGE 28 0.0003
765 FISTULA 3 0.0003
766 BLOOD CALCIUM DECREASED 3 0.0003
767 HYPONATRAEMIA 15 0.0003
768 HYPOCALCAEMIA 5 0.0003
769 SHOCK 6 0.0003
770 DRUG ADMINISTRATION ERROR 8 0.0003
771 SEIZURE 30 0.0003
772 GENERAL PHYSICAL HEALTH DETERIORATION 30 0.0003
773 VASCULITIS 3 0.0003
774 ORAL HERPES 5 0.0003
775 SPINAL PAIN 3 0.0003
776 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
777 CYANOSIS 4 0.0003
778 ARRHYTHMIA 12 0.0003
779 BLOOD IRON DECREASED 3 0.0003
780 HAEMATOCRIT DECREASED 5 0.0003
781 BLOOD ALBUMIN DECREASED 2 0.0003
782 DIARRHOEA 162 0.0003
783 COVID-19 44 0.0003
784 ATRIAL FLUTTER 2 0.0003
785 SENSORY DISTURBANCE 4 0.0002
786 ADRENAL INSUFFICIENCY 3 0.0002
787 HYPERGLYCAEMIA 9 0.0002
788 ASPHYXIA 2 0.0002
789 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
790 CARDIO-RESPIRATORY ARREST 10 0.0002
791 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
792 PERICARDITIS 4 0.0002
793 CIRCULATORY COLLAPSE 4 0.0002
794 INFLAMMATION 12 0.0002
795 BLOOD MAGNESIUM DECREASED 2 0.0002
796 CARDIAC MURMUR 2 0.0002
797 DIPLOPIA 6 0.0002
798 BRONCHITIS 17 0.0002
799 HYPERKALAEMIA 8 0.0002
800 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
801 CHILLS 26 0.0002
802 HEAD INJURY 7 0.0002
803 TACHYPNOEA 3 0.0002
804 ACUTE HEPATIC FAILURE 3 0.0002
805 BONE DISORDER 4 0.0002
806 CONFUSIONAL STATE 35 0.0002
807 DIVERTICULITIS 6 0.0002
808 LACTIC ACIDOSIS 7 0.0002
809 CONJUNCTIVITIS 4 0.0002
810 HYPOMAGNESAEMIA 3 0.0002
811 SEASONAL ALLERGY 3 0.0002
812 INFUSION RELATED REACTION 14 0.0002
813 EPISTAXIS 15 0.0002
814 BLOOD POTASSIUM DECREASED 6 0.0002
815 BRAIN INJURY 2 0.0002
816 PRODUCT USE ISSUE 37 0.0002
817 BLINDNESS 8 0.0002
818 PULMONARY HYPERTENSION 4 0.0002
819 DRUG-INDUCED LIVER INJURY 6 0.0002
820 DERMATITIS 4 0.0002
821 BRADYCARDIA 10 0.0002
822 ABSCESS 3 0.0002
823 EATING DISORDER 4 0.0002
824 BONE PAIN 11 0.0002
825 BLOOD CREATININE INCREASED 12 0.0002
826 PRODUCT PRESCRIBING ISSUE 4 0.0002
827 MELAENA 4 0.0002
828 HAEMOPTYSIS 5 0.0002
829 VOMITING 84 0.0002
830 LETHARGY 10 0.0002
831 SPEECH DISORDER 9 0.0002
832 URINARY INCONTINENCE 5 0.0002
833 CHOLECYSTITIS 2 0.0002
834 GASTROINTESTINAL HAEMORRHAGE 14 0.0002
835 TOOTHACHE 3 0.0002
836 THERAPEUTIC RESPONSE DECREASED 10 0.0002
837 NEURALGIA 4 0.0002
838 URINARY TRACT INFECTION 28 0.0002
839 ABDOMINAL PAIN 38 0.0002
840 OSTEONECROSIS OF JAW 4 0.0002
841 CONDITION AGGRAVATED 49 0.0002
842 HEPATIC STEATOSIS 3 0.0002
843 MUSCULOSKELETAL DISORDER 3 0.0002
844 HERNIA 3 0.0002
845 SKIN ULCER 4 0.0002
846 DRUG INEFFECTIVE 202 0.0002
847 CHOLELITHIASIS 5 0.0002
848 ASTHENIA 57 0.0002
849 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
850 DISORIENTATION 6 0.0002
851 CARDIAC FAILURE CONGESTIVE 12 0.0001
852 SOMNOLENCE 30 0.0001
853 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
854 FREQUENT BOWEL MOVEMENTS 4 0.0001
855 PRODUCTIVE COUGH 7 0.0001
856 POLLAKIURIA 6 0.0001
857 DEHYDRATION 19 0.0001
858 OXYGEN SATURATION DECREASED 8 0.0001
859 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
860 DRY EYE 7 0.0001
861 RED BLOOD CELL COUNT DECREASED 4 0.0001
862 BREAST CANCER 13 0.0001
863 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
864 APATHY 2 0.0001
865 DYSURIA 5 0.0001
866 DEATH 117 0.0001
867 GASTROINTESTINAL DISORDER 12 0.0001
868 CORONARY ARTERY DISEASE 4 0.0001
869 RASH 57 0.0001
870 COUGH 36 0.0001
871 HYPERTENSION 27 0.0001
872 CYSTITIS 4 0.0001
873 METABOLIC ACIDOSIS 4 0.0001
874 NIGHT SWEATS 4 0.0001
875 DYSPNOEA 69 0.0001
876 PARAESTHESIA 19 0.0001
877 GAIT DISTURBANCE 23 0.0001
878 DIABETES MELLITUS 9 0.0001
879 UNRESPONSIVE TO STIMULI 3 0.0001
880 NAUSEA 91 0.0001
881 HEADACHE 72 0.0001
882 DRUG INTOLERANCE 11 0.0001
883 LIVER DISORDER 5 0.0001
884 PROSTATE CANCER 9 0.0001
885 WEIGHT INCREASED 25 0.0001
886 DRUG EFFECT DECREASED 6 0.0001
887 SKIN DISCOLOURATION 5 0.0001
888 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
889 BLOOD SODIUM DECREASED 2 0.0001
890 PAIN IN JAW 3 0.0001
891 NEOPLASM MALIGNANT 7 0.0001
892 DECREASED APPETITE 24 0.0001
893 PREMATURE BABY 3 0.0001
894 INFLUENZA 11 0.0001
895 DRY MOUTH 8 0.0001
896 PSORIATIC ARTHROPATHY 4 0.0001
897 FLUID RETENTION 5 0.0001
898 THERAPY CESSATION 5 0.0001
899 LUNG NEOPLASM MALIGNANT 4 0.0001
900 ROAD TRAFFIC ACCIDENT 4 0.0001
901 MEMORY IMPAIRMENT 13 0.0001
902 CEREBROVASCULAR ACCIDENT 16 0.0001
903 RECTAL HAEMORRHAGE 4 0.0001
904 UNEVALUABLE EVENT 7 0.0001
905 ANAPHYLACTIC REACTION 5 0.0001
906 SKIN DISORDER 3 0.0001
907 WEIGHT DECREASED 25 0.0001
908 TYPE 2 DIABETES MELLITUS 3 0.0001
909 DEPRESSION 20 0.0001
910 SINUSITIS 9 0.0001
911 HAEMATURIA 3 0.0001
912 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
913 CARDIAC DISORDER 8 0.0001
914 RASH ERYTHEMATOUS 4 0.0001
915 ALOPECIA 16 0.0001
916 HYPOAESTHESIA 12 0.0001
917 ABDOMINAL PAIN LOWER 2 0.0001
918 LOSS OF CONSCIOUSNESS 10 0.0001
919 ANAPHYLACTIC SHOCK 2 0.0001
920 FATIGUE 60 0.0001
921 DISTURBANCE IN ATTENTION 4 0.0001
922 OEDEMA PERIPHERAL 9 0.0001
923 DYSPHAGIA 7 0.0001
924 HEPATIC ENZYME INCREASED 5 0.0001
925 VISION BLURRED 10 0.0001
926 INJURY 5 0.0001
927 SLEEP DISORDER 5 0.0001
928 OSTEOARTHRITIS 3 0.0001
929 HYPERSENSITIVITY 13 0.0001
930 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
931 BALANCE DISORDER 6 0.0001
932 VAGINAL HAEMORRHAGE 3 0.0001
933 CATARACT 4 0.0001
934 ABDOMINAL DISTENSION 7 0.0001
935 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
936 RENAL DISORDER 3 0.0001
937 NO ADVERSE EVENT 11 0.0001
938 FALL 20 0.0001
939 CHEST PAIN 11 0.0001
940 CHEST DISCOMFORT 6 0.0001
941 ERYTHEMA 12 0.0001
942 MUSCULOSKELETAL PAIN 3 0.0001
943 CONSTIPATION 12 0.0001
944 AGITATION 4 0.0001
945 ARTHROPATHY 3 0.0001
946 DYSGEUSIA 4 0.0001
947 BLISTER 3 0.0001
948 HALLUCINATION 4 0.0001
949 FLATULENCE 3 0.0001
950 CONTUSION 5 0.0001
951 BLADDER CANCER 3 0.0001
952 PAIN IN EXTREMITY 15 0.0001
953 FLUSHING 5 0.0000
954 AMNESIA 3 0.0000
955 MYOCARDIAL INFARCTION 8 0.0000
956 BLOOD PRESSURE DECREASED 3 0.0000
957 PRURITUS 17 0.0000
958 INJECTION SITE REACTION 3 0.0000
959 OROPHARYNGEAL PAIN 4 0.0000
960 SWELLING 4 0.0000
961 TREMOR 7 0.0000
962 DYSPEPSIA 4 0.0000
963 SYNCOPE 4 0.0000
964 ACNE 3 0.0000
965 HYPERHIDROSIS 5 0.0000
966 BACK PAIN 9 0.0000
967 PSORIASIS 5 0.0000
968 MYALGIA 6 0.0000
969 INTENTIONAL PRODUCT MISUSE 3 0.0000
970 ABDOMINAL PAIN UPPER 7 0.0000
971 OVERDOSE 7 0.0000
972 HEART RATE INCREASED 3 0.0000
973 DRY SKIN 4 0.0000
974 PAIN 18 0.0000
975 BURNING SENSATION 2 0.0000
976 JOINT SWELLING 3 0.0000
977 ANXIETY 7 0.0000
978 ADVERSE DRUG REACTION 2 0.0000
979 ADVERSE EVENT 2 0.0000
980 MALAISE 9 0.0000
981 BLOOD PRESSURE INCREASED 3 0.0000
982 URTICARIA 3 0.0000
983 ABDOMINAL DISCOMFORT 3 0.0000
984 ARTHRALGIA 7 0.0000
985 DIZZINESS 8 0.0000
986 BLOOD GLUCOSE INCREASED 3 0.0000
987 INSOMNIA 4 0.0000